Catalyst Biosciences Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.511

+0 (+0%)

At Close: Dec 14, 2023

Currently predicting for Mon, 29 Apr 2024

Trading levels for CBIO

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	0.511	.
		R2	0.511	.
		R1	0.511	.
Current price:			0.511
	Support	S1	0.511	.
		S2	0.511	.
		S3	0.511	.

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	0.550	7.57 %
		R2	0.539	5.42 %
		R1	0.530	3.66 %
Current price			0.511
	Support	S1	0.500	-2.21%
		S2	0.431	-15.67%
		S3	0.420	-17.86%

CBIO Predictions History

6 years ago
not me predicted that CBIO for 2017-06-05 is going $2.58 (-40.28%)

Rank:

7 years ago
JS predicted that CBIO for 2017-04-07 is going $7.38 (35.41%)

7 years ago
JS predicted that CBIO for 2016-12-29 is going $0.686 (-93.07%)

7 years ago
AJR predicted that CBIO for 2016-12-19 is going $0.790 (-93.95%)

Rank:

7 years ago
JS predicted that CBIO for 2016-12-19 is going $0.80 (-93.85%)

About Catalyst Biosciences

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);... CBIO Profile

Golden Star

Ticker	Date	Change	Price
MLI	Apr 19	11.73%	$52.28
LPLA	Apr 19	1.08%	$262.59
DOOR	Apr 18	0.274%	$131.39
LNG	Apr 17	1.63%	$156.81
FCN	Apr 16	3.70%	$207.62
ELV	Apr 16	6.45%	$506.97
AKR	Apr 05	5.14%	$16.53
ITCI	Apr 05	5.39%	$68.44
SARK	Mar 28	14.47%	$26.88
ARCC	Mar 25	2.53%	$20.12

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In